Laser Focus World is an industry bedrock—first published in 1965 and still going strong. We publish original articles about cutting-edge advances in lasers, optics, photonics, sensors, and quantum technologies, as well as test and measurement, and the shift currently underway to usher in the photonic integrated circuits, optical interconnects, and copackaged electronics and photonics to deliver the speed and efficiency essential for data centers of the future.

Our 80,000 qualified print subscribers—and 130,000 12-month engaged online audience—trust us to dive in and provide original journalism you won’t find elsewhere covering key emerging areas such as laser-driven inertial confinement fusion, lasers in space, integrated photonics, chipscale lasers, LiDAR, metasurfaces, high-energy laser weaponry, photonic crystals, and quantum computing/sensors/communications. We cover the innovations driving these markets.

Laser Focus World is part of Endeavor Business Media, a division of EndeavorB2B.

Laser Focus World Membership

Never miss any articles, videos, podcasts, or webinars by signing up for membership access to Laser Focus World online. You can manage your preferences all in one place—and provide our editorial team with your valued feedback.

Magazine Subscription

Can you subscribe to receive our print issue for free? Yes, you sure can!

Newsletter Subscription

Laser Focus World newsletter subscription is free to qualified professionals:

The Daily Beam

Showcases the newest content from Laser Focus World, including photonics- and optics-based applications, components, research, and trends. (Daily)

Product Watch

The latest in products within the photonics industry. (9x per year)

Bio & Life Sciences Product Watch

The latest in products within the biophotonics industry. (4x per year)

Laser Processing Product Watch

The latest in products within the laser processing industry. (3x per year)

Get Published!

If you’d like to write an article for us, reach out with a short pitch to Sally Cole Johnson: [email protected]. We love to hear from you.

Photonics Hot List

Laser Focus World produces a video newscast that gives a peek into what’s happening in the world of photonics.

Following the Photons: A Photonics Podcast

Following the Photons: A Photonics Podcast dives deep into the fascinating world of photonics. Our weekly episodes feature interviews and discussions with industry and research experts, providing valuable perspectives on the issues, technologies, and trends shaping the photonics community.

Editorial Advisory Board

  • Professor Andrea M. Armani, University of Southern California
  • Ruti Ben-Shlomi, Ph.D., LightSolver
  • James Butler, Ph.D., Hamamatsu
  • Natalie Fardian-Melamed, Ph.D., Columbia University
  • Justin Sigley, Ph.D., AmeriCOM
  • Professor Birgit Stiller, Max Planck Institute for the Science of Light, and Leibniz University of Hannover
  • Professor Stephen Sweeney, University of Glasgow
  • Mohan Wang, Ph.D., University of Oxford
  • Professor Xuchen Wang, Harbin Engineering University
  • Professor Stefan Witte, Delft University of Technology

Enovis Continues to Redefine Revision Knee Surgery with the Addition of EMPOWR™ Cones to EMPOWR Revision Knee™, Creating a Comprehensive Portfolio for Efficient Revision Procedures

WILMINGTON, DE, Aug. 20, 2024 (GLOBE NEWSWIRE) --  Enovis™ (NYSE: ENOV), an innovation-driven medical technology growth company, announced today the expansion of its EMPOWR Revision Knee™ system to include EMPOWR™ Cones. The addition of the stackable tibial, femoral, and diaphyseal cones increases options for treating bone defects, creating a comprehensive portfolio to support complex revision needs. The FDA cleared use of the EMPOWR™ Cones with EMPOWR Revision Knee™ earlier this year.

The EMPOWR Revision Knee™ system is designed to redefine revision knee arthroplasty through a streamlined yet comprehensive setup which reduces clutter in the operating room while allowing surgeons to fine-tune implant fit to each patient. EMPOWR’s femoral and tibial stackable augments can be used both medially and laterally to minimize excess inventory. The multifunctional instrumentation keeps the surgeon’s back table efficiently organized, streamlining revision procedures.

“The introduction of the EMPOWR Revision Knee fills a current market need for more efficient revision options, especially with growing interest in outpatient revision knee procedures,” said Louie Vogt, Group President of Enovis’ Reconstructive Business Group. “Now with the addition of the EMPOWR Cones, surgeons are better able to tailor revision surgeries with a modernized workflow and no decision fatigue.”

“With the addition of the EMPOWR Cones, I now have the added flexibility to help more patients with their knee revision needs,” said Dr. Leonard T. Buller1, a hip and knee surgeon at Indiana University Health. “The cones were easy to ream, fit as planned, and the dimensions are ideal for accommodating the widest spectrum of implants.”

Following his first use of the implant, Dr. Beau J. Kildow of University of Nebraska Medical Center reported that “It went very smooth. Even the femoral cone prep was simple, more so than the leading competitive brand and sat line to line.”

For more information about EMPOWR Revision Knee™, please visit enovis.com/empowr-revision-knee.

1,2Drs. Kildow and Buller are paid consultants of Enovis.

About Enovis
Enovis Corporation (NYSE: ENOV) is an innovation-driven, medical technology growth company dedicated to developing clinically differentiated solutions that generate measurably better patient outcomes and transform workflows. Powered by a culture of continuous improvement, global talent and innovation, the Company’s extensive range of products, services, and integrated technologies fuels active lifestyles in orthopedics and beyond. For more information about Enovis, please visit www.enovis.com.

Media Contact
Kristen McColpin
Director of Marketing Communications, Enovis Surgical
Kristen.McColpin@enovis.com


Primary Logo

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.